Michael Kohrman
Neurology with Special Qualifications in Child Neurology · Akron, OHNPI 1467529347
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Livanova USA, Inc. at 47.4% of the total. Reporting peaked in 2022 at $1,620 and has fallen 89.3% since, to $174 in 2025.
Across 52 payments — averaging $115.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$3K
- Neuropace, Inc.$885
- UCB, Inc.$775
- Vertex$413
- Mallinckrodt Enterprises LLC$247
- Medtronic$178
- plus $654 from 8 others
Across 25 payments — averaging $4269.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$78K
- UCB Biosciences Inc.$17K
- SK Life Science, Inc.$12K
What the payments were for
- Consulting fees$4137%
- Speaking & faculty fees$1,15219%
- Travel & lodging$1,62327%
- Food & beverage$2,81047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 25 | $2,845 |
| Neuropace, Inc. | 5 | $885 |
| UCB, Inc. | 6 | $775 |
| Vertex | 1 | $413 |
| Mallinckrodt Enterprises LLC | 4 | $247 |
| Medtronic | 1 | $178 |
| Jazz Pharmaceuticals Inc. | 2 | $171 |
| Biomarin Pharmaceutical Inc. | 1 | $109 |
| Amgen | 1 | $97 |
| Neurelis, Inc. | 2 | $96 |
| SK Life Science, Inc. | 1 | $66 |
| Zogenix Inc. | 1 | $46 |
| Zimmer Biomet | 1 | $36 |
| Monteris Medical Corporation | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,376
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$902
- RNS Neurostimulator Kit$851
- Briviact$268
- Fintepla$266
- VNS - Sentiva$250
- ACTHAR$230
- ACTIVA$178
- Brineura$109
How this compares
$5,999 in reported general payments places this provider in the 70th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XcopriCenobamate | 11 | $20,780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $66 | $20,78011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
Other neurology with special qualifications in child neurology in Akron
- Bruce CohenAkron$15K
- Matthew GinsbergAkron$8K
- Thiruvengadam KulasekaranAkron$4K
- Ian RossmanAkron$4K
- Sariha MoyenAkron$2K
- Lucyna ZawadzkiAkron$2K
- Nancy PhilipAkron$682
- Margaret McBrideAkron$350
- Hope O'BrienCincinnati$525K
- Ajay GuptaCleveland$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.